Home  »  Finance   »  Navigating BIOL Stock: BIOLASE Inc. Journey...

Navigating BIOL Stock: BIOLASE Inc. Journey

The stock of BIOLASE Inc. (BIOL) is currently priced at $0.16. In the last session, the stock climbed significantly, topping out at $0.174 after opening at $0.174. The day’s lowest price was $0.148 before the stock closed at $0.15.

BIOLASE Inc. experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $5.94 on 08/12/22, while the lowest price for the same period was registered at $0.10 on 05/18/23.

Top 5 EV Tech Stocks to Buy for 2023

According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.

Click Here to Download the FREE Report.


52-week price history of BIOL Stock

Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. BIOLASE Inc.’s current trading price is -97.30% away from its 52-week high, while its distance from the 52-week low is 61.04%. The stock’s price range during the 52-week period has remained between $0.10 and $5.94. In the Healthcare sector, the company’s shares saw a trading volume of around 1.64 million for the day, which was evidently higher than the average daily volume of 1.55 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

BIOLASE Inc. (BIOL) has experienced a quarterly decline of -64.75% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 4.22M and boasts a workforce of 188 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.3979, with a change in price of -0.4679. Similarly, BIOLASE Inc. recorded 1,277,889 in trading volume during the last 100 days, posting a change of -75.09%.

Examining BIOL’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for BIOL stands at 1.70. Similarly, the long-term debt-to-equity ratio is also 1.52.

BIOL Stock Stochastic Average

BIOLASE Inc.’s raw stochastic average for the past 50 days is presently 14.97%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 25.12%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 25.95% and 25.09%, respectively.

BIOL Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The metric has seen a significant loss of -75.32% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -90.45%. Over the past 30 days, the price of BIOL has leaped by -25.40%. And in the last five days, it has fallen by -8.08%.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts